40 million are due to arrive in Australia this year, with 60 million expected to be delivered in 2022 and 25 million in 2023.
In June, the ATAGI released a statement advising Pfizer as the preferred vaccine:
The Australian Technical Advisory Group on Immunisation (ATAGI) recommends the COVID-19 Pfizer vaccine (Comirnaty) as the preferred vaccine for those aged 16 to under 60 years. This updates the previous preferential recommendation for Comirnaty over COVID-19 Vaccine AstraZeneca in those aged 16 to under 50 years.
However, they have now backflipped and have advised anyone 18 or over in Greater Sydney "should strongly consider getting vaccinated with any available vaccine."
This comes after New South Wales recorded 163 new cases on Saturday.
Join Tom Tilley with regular rotating co-hosts Jan Fran, Annika Smethurst and Jamila Rizvi on The Briefing, Monday - Saturday, for the day's headlines and breaking news as well as hot topics and interviews. Available on Listnr.